• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?

作者信息

Dodwell D J, de Campos E S, Radford J A

机构信息

Cookridge Hospital, Leeds, England.

出版信息

Drugs. 1992 Jul;44(1):1-8. doi: 10.2165/00003495-199244010-00001.

DOI:10.2165/00003495-199244010-00001
PMID:1379906
Abstract
摘要

相似文献

1
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Drugs. 1992 Jul;44(1):1-8. doi: 10.2165/00003495-199244010-00001.
2
[Chemotherapy of malignant lymphomas].[恶性淋巴瘤的化学疗法]
Radiol Med. 1976 Jul-Aug;62(7-8):553-7.
3
Chemotherapy of Hodgkin's disease.霍奇金病的化学疗法。
Nouv Rev Fr Hematol (1978). 1990;32(2):169-73.
4
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.MACOP-B方案与ProMACE-MOPP方案治疗晚期弥漫性非霍奇金淋巴瘤：非霍奇金淋巴瘤协作研究组前瞻性随机试验结果
J Clin Oncol. 1994 Jul;12(7):1366-74. doi: 10.1200/JCO.1994.12.7.1366.
5
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.博来霉素、依托泊苷、阿霉素、环磷酰胺、长春新碱、丙卡巴肼和泼尼松方案用于晚期霍奇金淋巴瘤的14天变体：德国霍奇金淋巴瘤研究组的一项试点研究结果
J Clin Oncol. 2003 May 1;21(9):1734-9. doi: 10.1200/JCO.2003.06.028.
6
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].[骨髓自体移植在霍奇金淋巴瘤和非霍奇金淋巴瘤治疗中的地位]
Nouv Rev Fr Hematol (1978). 1988;30(1-2):131-4.
7
[Hematologic tumors].
Gan To Kagaku Ryoho. 2003 Oct;30(10):1416-21.
8
What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?晚期霍奇金淋巴瘤的首选治疗方案是什么：ABVD方案、斯坦福V方案还是BEACOPP方案？
Curr Hematol Rep. 2004 Jan;3(1):17-26.
9
[CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Rinsho Ketsueki. 1984 Feb;25(2):164-8.
10
Chemotherapy in Hodgkin's disease.霍奇金淋巴瘤的化疗
Indian Pediatr. 1996 Jul;33(7):561-5.

本文引用的文献

1
Dose: a critical factor in cancer chemotherapy.剂量：癌症化疗中的关键因素。
Am J Med. 1980 Oct;69(4):585-94. doi: 10.1016/0002-9343(80)90472-6.
2
A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.用MOPP化疗治疗霍奇金病的剂量和时间反应分析。
J Clin Oncol. 1983 Feb;1(2):146-53. doi: 10.1200/JCO.1983.1.2.146.
3
Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology.
Cancer. 1984 Sep 15;54(6 Suppl):1160-7. doi: 10.1002/1097-0142(19840915)54:1+<1160::aid-cncr2820541312>3.0.co;2-p.
4
The importance of dose intensity in chemotherapy of metastatic breast cancer.剂量强度在转移性乳腺癌化疗中的重要性。
J Clin Oncol. 1984 Nov;2(11):1281-8. doi: 10.1200/JCO.1984.2.11.1281.
5
Alternating drug combinations in the treatment of advanced Hodgkin's disease.交替使用药物组合治疗晚期霍奇金淋巴瘤。
N Engl J Med. 1982 Apr 1;306(13):770-5. doi: 10.1056/NEJM198204013061303.
6
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
Ann Intern Med. 1982 Feb;96(2):139-43. doi: 10.7326/0003-4819-96-2-139.
7
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.正常造血及移植淋巴瘤集落形成细胞对体内给予的化疗药物敏感性的比较。
J Natl Cancer Inst. 1966 Aug;37(2):233-45.
8
Biochemical, biological, pharmacologic, toxicologic, kinetic and clinical (subhuman and human) relationships.生化、生物学、药理学、毒理学、动力学及临床（非人及人类）关系。
Cancer. 1968 Apr;21(4):600-10. doi: 10.1002/1097-0142(196804)21:4<600::aid-cncr2820210409>3.0.co;2-m.
9
Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
J Clin Oncol. 1985 Dec;3(12):1596-604. doi: 10.1200/JCO.1985.3.12.1596.
10
The description of chemotherapy delivery: options and pitfalls.化疗给药的描述：选择与陷阱
Semin Oncol. 1987 Dec;14(4 Suppl 4):34-42.